Healthy ageing through internet counselling in the elderly (HATICE): a multinational, randomised controlled trial.


Journal

The Lancet. Digital health
ISSN: 2589-7500
Titre abrégé: Lancet Digit Health
Pays: England
ID NLM: 101751302

Informations de publication

Date de publication:
12 2019
Historique:
received: 14 09 2019
accepted: 01 10 2019
entrez: 16 12 2020
pubmed: 17 12 2020
medline: 29 1 2021
Statut: ppublish

Résumé

Although web-based interventions have been promoted for cardiovascular risk management over the past decade, there is limited evidence for effectiveness of these interventions in people older than 65 years. The healthy ageing through internet counselling in the elderly (HATICE) trial aimed to determine whether a coach-supported internet intervention for self-management can reduce cardiovascular risk in community-dwelling older people. This prospective open-label, blinded endpoint clinical trial among people age 65 years or over at increased risk of cardiovascular disease randomly assigned participants in the Netherlands, Finland, and France to an interactive internet intervention stimulating coach-supported self-management or a control platform. Primary outcome was the difference from baseline to 18 months on a standardised composite score (Z score) of systolic blood pressure, LDL cholesterol, and body-mass index (BMI). Secondary outcomes included individual risk factors and cardiovascular endpoints. This trial is registered with the ISRCTN registry, 48151589, and is closed to accrual. Among 2724 participants, complete primary outcome data were available for 2398 (88%). After 18 months, the primary outcome improved in the intervention group versus the control group (0·09 vs 0·04, respectively; mean difference -0·05, 95% CI -0·08 to -0·01; p=0·008). For individual components of the primary outcome, mean differences (intervention vs control) were systolic blood pressure -1·79 mm Hg versus -0·67 mm Hg (-1·12, -2·51 to 0·27); BMI -0·23 kg/m Coach-supported self-management of cardiovascular risk factors using an interactive internet intervention is feasible in an older population, and leads to a modest improvement of cardiovascular risk profile. When implemented on a large scale this could potentially reduce the burden of cardiovascular disease. European Commission Seventh Framework Programme.

Sections du résumé

BACKGROUND
Although web-based interventions have been promoted for cardiovascular risk management over the past decade, there is limited evidence for effectiveness of these interventions in people older than 65 years. The healthy ageing through internet counselling in the elderly (HATICE) trial aimed to determine whether a coach-supported internet intervention for self-management can reduce cardiovascular risk in community-dwelling older people.
METHODS
This prospective open-label, blinded endpoint clinical trial among people age 65 years or over at increased risk of cardiovascular disease randomly assigned participants in the Netherlands, Finland, and France to an interactive internet intervention stimulating coach-supported self-management or a control platform. Primary outcome was the difference from baseline to 18 months on a standardised composite score (Z score) of systolic blood pressure, LDL cholesterol, and body-mass index (BMI). Secondary outcomes included individual risk factors and cardiovascular endpoints. This trial is registered with the ISRCTN registry, 48151589, and is closed to accrual.
FINDINGS
Among 2724 participants, complete primary outcome data were available for 2398 (88%). After 18 months, the primary outcome improved in the intervention group versus the control group (0·09 vs 0·04, respectively; mean difference -0·05, 95% CI -0·08 to -0·01; p=0·008). For individual components of the primary outcome, mean differences (intervention vs control) were systolic blood pressure -1·79 mm Hg versus -0·67 mm Hg (-1·12, -2·51 to 0·27); BMI -0·23 kg/m
INTERPRETATION
Coach-supported self-management of cardiovascular risk factors using an interactive internet intervention is feasible in an older population, and leads to a modest improvement of cardiovascular risk profile. When implemented on a large scale this could potentially reduce the burden of cardiovascular disease.
FUNDING
European Commission Seventh Framework Programme.

Identifiants

pubmed: 33323224
pii: S2589-7500(19)30153-0
doi: 10.1016/S2589-7500(19)30153-0
pii:
doi:

Banques de données

ISRCTN
['ISRCTN48151589']

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e424-e434

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Edo Richard (E)

Department of Neurology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands; Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Nijmegen, Netherlands. Electronic address: e.richard@amsterdamumc.nl.

Eric P Moll van Charante (EP)

Department of Primary Care, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands.

Marieke P Hoevenaar-Blom (MP)

Department of Neurology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands.

Nicola Coley (N)

INSERM, University of Toulouse UMR1027, Toulouse, France; Department of Epidemiology and Public Health, Toulouse University Hospital, Toulouse, France.

Mariagnese Barbera (M)

Institute of Clinical Medicine, Neurology, University of Eastern Finland, Kuopio, Finland.

Abraham van der Groep (A)

Vital Health Software, Ede, Netherlands.

Yannick Meiller (Y)

Department of Information and Operations Management, ESCP Europe, Paris, France.

Francesca Mangialasche (F)

Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden; Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University, Stockholm, Sweden.

Cathrien B Beishuizen (CB)

Department of Neurology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands.

Susan Jongstra (S)

Department of Neurology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands.

Tessa van Middelaar (T)

Department of Neurology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands.

Lennard L Van Wanrooij (LL)

Department of Neurology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands.

Tiia Ngandu (T)

Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden; Public Health Promotion Unit, National Institute for Health and Welfare, Helsinki, Finland.

Juliette Guillemont (J)

INSERM, University of Toulouse UMR1027, Toulouse, France.

Sandrine Andrieu (S)

INSERM, University of Toulouse UMR1027, Toulouse, France; Department of Epidemiology and Public Health, Toulouse University Hospital, Toulouse, France.

Carol Brayne (C)

Department of Public Health and Primary Care, Cambridge Institute of Public Health, University of Cambridge, UK.

Miia Kivipelto (M)

Institute of Clinical Medicine, Neurology, University of Eastern Finland, Kuopio, Finland; Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland; Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden; Neuroepidemiology and Aging Unit, School of Public Health, Imperial College London, UK.

Hilkka Soininen (H)

Institute of Clinical Medicine, Neurology, University of Eastern Finland, Kuopio, Finland; Neurocenter, Neurology, Kuopio University Hospital, Kuopio, Finland.

Willem A Van Gool (WA)

Department of Neurology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH